Which ETFs hold Takeda Pharmaceutical Co Ltd (4502)?
Japanese pharmaceutical company with medicines for gastrointestinal disease, rare diseases, cancer and plasma therapies.
23 Australian ETFs hold Takeda Pharmaceutical Co Ltd, a Health Care company from Japan. HJPN has the biggest weighting at 1.56%. Across these funds, Australian ETF investors own about $89m of Takeda Pharmaceutical Co Ltd.
The ETFs with the most Takeda Pharmaceutical Co Ltd
All 23 ETFs that hold Takeda Pharmaceutical Co Ltd, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Takeda Pharmaceutical Co Ltd.
Common questions
Which ETF has the most Takeda Pharmaceutical Co Ltd?
HJPN (Betashares Japan Currency Hedged ETF) has the highest weighting, with 1.56% of the fund in Takeda Pharmaceutical Co Ltd.
What is the cheapest ETF that holds Takeda Pharmaceutical Co Ltd?
Of the ETFs where Takeda Pharmaceutical Co Ltd is at least 1% of the fund, WDIV has the lowest fee at 0.35% a year, with 1.15% in Takeda Pharmaceutical Co Ltd.
How much Takeda Pharmaceutical Co Ltd do I own with $10,000 in VGS?
About $6. VGS is the largest ETF that holds Takeda Pharmaceutical Co Ltd, and Takeda Pharmaceutical Co Ltd makes up 0.07% of it.
How many Australian ETFs hold Takeda Pharmaceutical Co Ltd?
23 ETFs listed on the ASX or TMX Australia hold Takeda Pharmaceutical Co Ltd, based on issuers' published holdings.